Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Site Announcement

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Investors
  • Overview
  • Corporate News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Leadership
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • IRS Form 8937 for 2019 Reverse Stock Split
    • IRS Form 8937 for 2023 Reverse Stock Split
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
  • Analyst Coverage

Press Releases

  • Corporate News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Nov 14, 2022

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Nov 2, 2022

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022

Sep 6, 2022

Aethlon Medical to Present at Two Investor Conferences in September

Aug 9, 2022

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

Aug 3, 2022

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022

Jul 28, 2022

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

Jul 11, 2022

Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment

Jun 28, 2022

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

Jun 21, 2022

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022

May 17, 2022

/C O R R E C T I O N -- Aethlon Medical, Inc./

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.